Balance in the Strabismic Patient Undergoing Strabismus Surgery
NCT ID: NCT06733220
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2025-02-05
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In about 4% of the young population, the sensory and/or motor pathways are not adequately developed, resulting in misalignment of the visual axes and strabismus. Eye surgery for strabismus is one of the most widely used treatment methods.
Only a few studies in the literature have analyzed changes in postural control after strabismus surgery and on a limited number of patients.
A French study evaluated the effect of surgery on postural control in children with strabismus, concluding that eye surgery affects the somatosensory properties of extraocular muscles, leading to improved postural control and that binocular visual perception could affect the whole body.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strabismus Surgery and Driving Ability
NCT02570555
Strabismus Measurements Using Automated 3D Video Oculography
NCT02228070
Lateral Rectus Resection Versus Lateral Rectus Plication in Patients With Residual Esotropia
NCT04213768
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
NCT04310241
Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child
NCT02360969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will undergo clinical evaluation and assessment of balance and fall risk at all assessment timepoints
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STR-CONG
Patients with congenital strabismus will undergo a comprehensive eye and orthoptic examination and balance test before strabismus surgery at 30 days after surgery, at 90 days after surgery, and at 180 days after surgery.
Surgery for strabismus
Patients will undergo surgery to correct strabismus, congenital or acquired
STR-ACQ
Patients with acquired strabismus will undergo a comprehensive eye and orthoptic examination and balance test before strabismus surgery, at 30 days after surgery, at 90 days after surgery, and at 180 days after surgery.
Surgery for strabismus
Patients will undergo surgery to correct strabismus, congenital or acquired
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgery for strabismus
Patients will undergo surgery to correct strabismus, congenital or acquired
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of congenital strabismus or acquired strabismus in the care of the Ophthalmology OU, the Diagnosis and Treatment of Ocular Motility Disorders OU, and the Pediatric Ophthalmology Outpatient Clinic
* Ability to maintain balance safely for at least 180 seconds;
* In case of adult patient, Ability to understand and sign informed consent
* In case of minor patient, Ability to understand and sign the assent for participation in the study and consent from the parent
Exclusion Criteria
* Presence of psychomotor and cognitive delay, as assessed by the Mini Mental State Examination (adjusted score \< 24);
* Noncooperation of the patient;
* Inability to provide informed consent, in the case of adult patients.
* Inability to provide consent in case of minor patients, or consent from parents.
16 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salerni Annabella
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annabella Salerni, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.